Webcasts & Podcasts

When: Tuesday, June 25^th, 2013 @ 11:30am ET

Despite its rich pipeline, cardiovascular device innovation is declining. Both the cost and development time required to bring devices to market have increased in recent years. Tune in to our webcast to learn more about the cardiovascular device research pipeline and approval trends.

When: May 22nd, 2013 @ 11:30am ET

Current EU legislation on medical devices is outdated (some directives are more than 20 years old) and often inconsistently interpreted by member states. Tune in to learn more about the challenges facing EU nations with the modernization and expansion of medical device regulations and how...

Despite remarkable advances in medical research and treatments, infectious diseases remain a very serious threat, causing about one in four deaths worldwide. Tune in to our webcast to learn about emerging global trends in infectious disease drug development and how we can begin to tackle these challenges through regulatory and technology considerations.

An estimated 3% of US adult cancer patients participate in clinical trials. The low participation rate is a major bottleneck in developing new cancer treatments. A key factor in progress toward better treatment and prognosis in adult oncology lies in improving participation rates.

Learn more about the emerging changes to the standard interpretation of laws governing the import of clinical trial supplies into the US and to explore best practices for overcoming this latest hurdle.

Digital CROs set themselves apart from traditional CROs by leveraging innovative, technology-amplified tools and processes to deliver more efficient and effective clinical trial management services. Join our panel of experts for an interactive presentation on this technology-amplified approach to clinical trial management.

On-site monitoring accounts for up to 30% of your study costs. It’s in your best interest to work with a CRO using the best, most efficient methods for study oversight and quality assurance. Join our panel of experts for an interactive discussion to learn how the use of a technology-amplified, real-time, risk-based approach to monitoring can help.

With pressure on global pharma and biotech companies to bring products to market faster while also cutting costs, many have turned their focus to streamlining study start-ups. While some factors are outside of a sponsor’s direct control, there are strategies sponsors can implement to positively impact start-up timelines.

Pioneering novel therapeutics is always an uncertain endeavor. Thus, the story of therapeutic cancer vaccine development has its share of challenges, but they are not insurmountable.  View this FREE on-demand Clinipace Worldwide event as we discuss the importance of having the right regulatory and clinical development strategies for success.